Principal Investigators

    Prof Christopher Rowe


    Institute for Breathing and Sleep

    Contact information of lead PI



    Title of project or programme

    AIBL III - Efficient identification of preclinical AD

    Source of funding information

    National Health and Medical Research Council

    Total sum awarded (Euro)

    € 490,392

    Start date of award


    Total duration of award in years



    Research Abstract

    Amyloid brain scans can detect the onset of Alzheimer’s disease 10-15 years before symptoms first appear. Amyloid build-up is thought to be the cause of Alzheimer’s disease. The earlier that drugs designed to slow the build up of amyloid or to clear it from the brain are given, the greater the chance of benefit. This study will use the recent discoveries from the Australian AIBL study to develop the best method to find these people with brain amyloid but no symptoms for early treatment trials to prevent dementia.

    Further information available at:

Types: Investments < €500k
Member States: Australia
Diseases: N/A
Years: 2016
Database Categories: N/A
Database Tags: N/A

Export as PDF